Replimune REPL
NASDAQ REPL
$11.72 +0.30 (+2.63%)
At close: Oct 21, 2026 · 4:00 PM EDT

Replimune (REPL) Net Margin (2017 - 2018)

Updated

Analysis

Replimune (REPL) Net Margin (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Replimune 1.14 Bn 79.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -869.95%
Sep 30, 2018 -973.04%
Jun 30, 2018 -4,424.67%
Dec 31, 2017 -13,606.25%
Sep 30, 2017 -46,600.00%
Jun 30, 2017 -11,840.00%
API Access

Replimune Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=REPL&period=max&api_key=YOUR_API_KEY